Information on New Approvals and Medication Safety
Search results for: gout flare
Drug Updates
Information on New Approvals and Medication Safety
Colcrys Approval Triggers Questions
Some rheumatologists question the depth of research and the approval’s implications for patient access
ALERT: 2010 ICD-9-CM/CPT Code Changes
As of January 1, physicians can no longer bill the inpatient/outpatient consultation evaluation and management (E/M) codes for Medicare patients. E/M codes for new or established patients should be used as appropriate.
ALERT: 2010 ICD-9-CM/CPT Code Changes
As of January 1, physicians can no longer bill the inpatient/outpatient consultation evaluation and management (E/M) codes for Medicare patients. E/M codes for new or established patients should be used as appropriate.
Reading Rheum
Handpicked Reviews of Contemporary Literature
Secrets & Pearls of Rheumatology at ACR Convergence 2025
Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.
Calcium Pyrophosphate Deposition Disease Diagnosis & Treatment Gaps Remain
CPPD diagnosis is difficult & treatments are limited. Experts review radiology challenges, off-label options like colchicine, & emerging biologics.
Calcium Pyrophosphate Deposition Disease: The Great Mimic
CPPD is notoriously difficult to diagnose due to its diverse presentations & uncertain etiology. Recent advances have helped rheumatologists better understand its risk factors, classify, diagnose & treat the condition.
AI’s Expanding Role in Rheumatology & Healthcare
Disease detection, access to care and remote patient monitoring are just a few areas in which AI is expected to aid rheumatology, but there will still be room for the human touch.
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 17
- Next Page »